The Cell Biology/Morphology Core will provide services to all 5 projects of the PPG. Services of the Core will be provided by two Facilities: the Cell Biology and the Morphology Facilities. The Cell Biology Facility serves two primary functions: (a) isolation of different cell populations from mouse livers for Projects 3 and 4. The Facility will also prepare and deliver differentiated murine neutrophils to Project 4, (b) isolation and maintenance of endothelial cells derived from human umbilical veins and arteries for Project 5. A centralized Cell Biology Facility will greatly reduce the cost of performing cell isolation and tissue culture by individual projects and will ensure a high degree of uniformity of hepatic cell and endothelial cell preparations and cultures. The Morphology Facility will serve Projects. The primary functions of this Facility are to prepare tissue samples for of routine histology and immunolocalization of adhesion molecules, cytokines, and enzymes for Projects. Additionally, confocal microscopy services will be provided to Projects 0010 and 0009 to visualize neutrophil-endothelial cell interaction, and postanoxic changes in endothelial junctional integrity. Consolidation of all morphology and imaging needs of the projects into a centralized Morphology Facility will reduce cost and maintain consistency in the quality of the work performed. Dr. Aw will serve as the Core Director and will be assisted by Drs. Alexander, Specian, and Fuseler. The Core Director and Co-Directors will meet monthly with individual Project leaders to review performance of the Core and a progress report will be presented to all PPG investigators at our monthly business meeting.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
2P01DK043785-11A1
Application #
6587528
Study Section
Special Emphasis Panel (ZDK1)
Project Start
2002-07-01
Project End
2007-06-30
Budget Start
Budget End
Support Year
11
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Louisiana State University Hsc Shreveport
Department
Type
DUNS #
City
Shreveport
State
LA
Country
United States
Zip Code
71103
Ma, Yuxiang; Okazaki, Yasumasa; Glass, Jonathan (2018) A fluorescent metal-sensor study provides evidence for iron transport by transcytosis in the intestinal epithelial cells. J Clin Biochem Nutr 62:49-55
Hozumi, Hideaki; Russell, Janice; Vital, Shantel et al. (2016) IL-6 Mediates the Intestinal Microvascular Thrombosis Associated with Experimental Colitis. Inflamm Bowel Dis 22:560-8
Souza, Daniele G; Senchenkova, Elena Y; Russell, Janice et al. (2015) MyD88 mediates the protective effects of probiotics against the arteriolar thrombosis and leukocyte recruitment associated with experimental colitis. Inflamm Bowel Dis 21:888-900
Yan, Serena L S; Russell, Janice; Granger, D Neil (2014) Platelet activation and platelet-leukocyte aggregation elicited in experimental colitis are mediated by interleukin-6. Inflamm Bowel Dis 20:353-62
Carter, Patsy R; Watts, Megan N; Kosloski-Davidson, Melissa et al. (2013) Iron status, anemia, and plasma erythropoietin levels in acute and chronic mouse models of colitis. Inflamm Bowel Dis 19:1260-5
Cromer, Walter E; Ganta, Chaitanya V; Patel, Mihir et al. (2013) VEGF-A isoform modulation in an preclinical TNBS model of ulcerative colitis: protective effects of a VEGF164b therapy. J Transl Med 11:207
Senchenkova, Elena Y; Komoto, Shunsuke; Russell, Janice et al. (2013) Interleukin-6 mediates the platelet abnormalities and thrombogenesis associated with experimental colitis. Am J Pathol 183:173-81
Yan, Serena L S; Russell, Janice; Harris, Norman R et al. (2013) Platelet abnormalities during colonic inflammation. Inflamm Bowel Dis 19:1245-53
Singer, Georg; Stokes, Karen Y; Neil Granger, D (2013) Reactive oxygen and nitrogen species in sepsis-induced hepatic microvascular dysfunction. Inflamm Res 62:155-64
Watts, Megan N; Eshaq, Randa S; Carter, Patsy R et al. (2013) Decreased retinal blood flow in experimental colitis; improvement by eye drop administration of losartan. Exp Eye Res 115:22-6

Showing the most recent 10 out of 364 publications